Invesco
ZLAB icon

Invesco’s Zai Lab ZLAB Stock Holding History

Invesco’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$500K Sell
26,558
-4,036
-13% -$74.8K ﹤0.01% 3164
2025
Q4 		$540K Sell
30,594
-7,960
-21% -$186K ﹤0.01% 3168
2025
Q3 		$1.31M Sell
38,554
-9,045
-19% -$311K ﹤0.01% 2809
2025
Q2 		$1.66M Sell
47,599
-6,945
-13% -$228K ﹤0.01% 2638
2025
Q1 		$1.97M Buy
54,544
+10,204
+23% +$314K ﹤0.01% 2558
2024
Q4 		$1.16M Buy
44,340
+1,790
+4% +$49.7K ﹤0.01% 2860
2024
Q3 		$1.03M Sell
42,550
-1,456
-3% -$27.5K ﹤0.01% 2897
2024
Q2 		$763K Sell
44,006
-1,337
-3% -$23.5K ﹤0.01% 3079
2024
Q1 		$726K Sell
45,343
-1,848,186
-98% -$38.9M ﹤0.01% 3153
2023
Q4 		$51.8M Sell
1,893,529
-1,315,774
-41% -$34.7M 0.01% 990
2023
Q3 		$78M Sell
3,209,303
-403,158
-11% -$10.7M 0.02% 798
2023
Q2 		$100M Sell
3,612,461
-1,190,165
-25% -$38.9M 0.03% 726
2023
Q1 		$160M Sell
4,802,626
-3,428,410
-42% -$132M 0.04% 556
2022
Q4 		$253M Sell
8,231,036
-95,093
-1% -$3M 0.07% 376
2022
Q3 		$285M Buy
8,326,129
+49,696
+0.6% +$2.13M 0.09% 298
2022
Q2 		$287M Buy
8,276,433
+18,315
+0.2% +$646K 0.09% 307
2022
Q1 		$363M Buy
8,258,118
+1,006,575
+14% +$48.7M 0.09% 279
2021
Q4 		$456M Buy
7,251,543
+2,552,103
+54% +$216M 0.11% 218
2021
Q3 		$495M Buy
4,699,440
+3,285,522
+232% +$472M 0.13% 191
2021
Q2 		$250M Buy
1,413,918
+1,286,327
+1,008% +$207M 0.06% 412
2021
Q1 		$17M Sell
127,591
-17,311
-12% -$2.68M ﹤0.01% 1647
2020
Q4 		$19.6M Buy
144,902
+13,365
+10% +$1.36M 0.01% 1441
2020
Q3 		$10.9M Buy
131,537
+21,760
+20% +$1.75M ﹤0.01% 1614
2020
Q2 		$9.02M Buy
109,777
+78,408
+250% +$5.3M ﹤0.01% 1693
2020
Q1 		$1.61M Sell
31,369
-16,783
-35% -$875K ﹤0.01% 2509
2019
Q4 		$2M Buy
48,152
+658
+1% +$24.3K ﹤0.01% 2644
2019
Q3 		$1.54M Buy
47,494
+10,242
+27% +$351K ﹤0.01% 2769
2019
Q2 		$1.3M Sell
37,252
-1,468
-4% -$43.2K ﹤0.01% 2920
2019
Q1 		$1.14M Buy
38,720
+149
+0.4% +$4.08K ﹤0.01% 2949
2018
Q4 		$896K Buy
38,571
+15,069
+64% +$279K ﹤0.01% 3037
2018
Q3 		$458K Buy
23,502
+8,945
+61% +$194K ﹤0.01% 3465
2018
Q2 		$338K Sell
14,557
-3,458
-19% -$74.6K ﹤0.01% 3562
2018
Q1 		$385K Buy
+18,015
New +$409K ﹤0.01% 3424

Other funds holding ZLAB

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Invesco's ZLAB Position: Q1 2026 in Review

Invesco reduced its Zai Lab (ZLAB) stake by 13% in Q1 2026, selling an estimated $74.8K and leaving 26,558 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #3164.

Invesco first reported a position in ZLAB in Q1 2018 and has held it in 33 quarters since. The position peaked at $495M in Q3 2021. 99 funds tracked by Wall St. Rank hold ZLAB as of Q1 2026.

  • Invesco held 26,558 shares of Zai Lab worth $500K as of Q1 2026.
  • Invesco sold 4,036 Zai Lab shares in Q1 2026, an estimated $74.8K.
  • Zai Lab made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3164 holding.
  • Invesco first reported a position in Zai Lab in Q1 2018 and has held it in 33 quarters since.
  • Invesco's Zai Lab position peaked at $495M in Q3 2021.
  • 99 funds tracked by Wall St. Rank held Zai Lab as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.